Expression of the ErbB Family of Receptors in Ovarian Cancer

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of the Society for Gynecologic Investigation

• Publication date

  1998-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1177/107155769800500310PMID 9614647
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dimerization of Cell Surface Receptors in Signal Transduction Review

  2004cited by this paper
• Epidermal growth factor receptor-immunohistochemical detection and clinical significance for treatment of primary breast cancer.

  1997cited by this paper
• Expression of a truncated epidermal growth factor receptor-like protein (TEGFR) in ovarian cancer.

  1997cited by this paper
• Expression of epidermal growth factor and androgen receptors in ovarian cancer.

  1997cited by this paper
• Activation of epidermal growth factor receptor gene transcription by phorbol 12-myristate 13-acetate is mediated by activator protein 2.

  1996cited by this paper
• Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.

  1996cited by this paper
• A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor

  1996cited by this paper
• Dimerization of cell surface receptors in signal transduction.

  1995cited by this paper
• The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction.

  1995cited by this paper
• c-erbB-3 protein expression in ovarian tumours.

  1995cited by this paper
• Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research

  1995cited by this paper
• The MAPK signaling cascade

  1995cited by this paper
• c‐erbb growth‐factor‐receptor proteins in ovarian tumours

  1995cited by this paper
• EGF-R and overexpression of the oncogene c-erbB-2 in ovarian cancer: immunohistochemical findings and prognostic value.

  1995cited by this paper
• PROTEIN-TYROSINE KINASES AND THEIR SIGNAL TRANSDUCTION PATHWAYS

  1994cited by this paper
• Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor

  1994cited by this paper
• Receptor protein-tyrosine kinases and their signal transduction pathways.

  1994cited by this paper
• Glucocorticoids stabilize HER-2/neu messenger RNA in human epithelial ovarian carcinoma cells.

  1994cited by this paper
• Structural and functional aspects of the multiplicity of Neu differentiation factors

  1994cited by this paper
• ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor

  1994cited by this paper
• The Family of c-erbB Genes: From Basic Research to Clinical Oncology

  1994cited by this paper
• Neu and its ligands: From an oncogene to neural factors

  1993cited by this paper
• Signalling by receptor tyrosine kinases.

  1993cited by this paper
• EGF receptor in neoplasia and metastasis

  1993cited by this paper
• Signaling by Receptor Tyrosine Kinases

  1993cited by this paper
• The type 1 (EGFR-related) family of growth factor receptors and their ligands.

  1992cited by this paper
• Significance of epidermal growth factor receptor in advanced ovarian cancer.

  1992cited by this paper
• Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer.

  1991cited by this paper
• 4. The role of the epidermal growth factor receptor and the c‐erbB‐2 protein in breast cancer

  1990cited by this paper
• Signal transduction by receptors with tyrosine kinase activity.

  1990cited by this paper
• Hormonal modulation of HER-2/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines.

  1990cited by this paper
• Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors.

  1989cited by this paper
• Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts.

  1989cited by this paper
• Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

  1989cited by this paper
• Regulation of epidermal growth factor receptor by progestins and glucocorticoids in human breast cancer cell lines

  1989cited by this paper
• A novel effect of EGF on mRNA stability.

  1988cited by this paper
• Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

  1987cited by this paper
• Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer.

  1987cited by this paper

• Human epidermal growth factor receptor targeted inhibitors for the treatment of ovarian cancer

  2018cites this paper
• Targeted Molecular Therapy for Patients with Ovarian Cancer

  2014cites this paper
• Synergistic Chemoimmunotherapy of Epithelial Ovarian Cancer Using ErbB-Retargeted T Cells Combined with Carboplatin

  2013cites this paper
• Gene Expression Analyses Support Fallopian Tube Epithelium as the Cell of Origin of Epithelial Ovarian Cancer

  2013cites this paper
• Carboplatin ErbB-Retargeted T Cells Combined with Epithelial Ovarian Cancer Using Synergistic Chemoimmunotherapy of Ghaem-Maghami and

  2013cites this paper
• The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer

  2011cites this paper
• Novel therapeutic targets.

  2009cites this paper
• Effects of small interfering RNAs targeting MAPK1 on gene expression profile in HeLa cells as revealed by microarray analysis

  2008cites this paper
• Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors.

  2008cites this paper
• Synthesis of Water Soluble Bis‐triazenoquinazolines: An Unusual Predicted Mode of Binding to the Epidermal Growth Factor Receptor Tyrosine Kinase

  2008cites this paper
• Expression of ErbB-1 and 2 in vestibular schwannomas.

  2007cites this paper
• HER-2/neu Genamplifikation und Rezeptorüberexpression in verschiedenen Tumoren des Ovars

  2007cites this paper
• The combi-targeting concept: evidence for the formation of a novel inhibitor in vivo

  2006cites this paper
• Multicenter, randomized phase II trial of oral CI-1033 for previously treated advanced ovarian cancer.

  2005cites this paper
• Chemosensitization to Platinum-Based Anticancer Drugs

  2004cites this paper
• Her-2/neu expression in ovarian cancer: pre- and postexposure to platinum chemotherapy.

  2003cites this paper
• Biologic directed therapies in gynecologic oncology

  2003cites this paper
• Autocrine heregulin generates growth factor independence and blocks apoptosis in colon cancer cells

  2002cites this paper
• An investigation of the role of the ErbB receptor family in chemotherapeutic drug resistance and invasion in human breast cancer

  2002cites this paper
• Overexpression of extracellular-signal regulated kinases on oral squamous cell carcinoma.

  2002cites this paper
• Prognostic Factors in Early Stages (FIGO I-II) of Epithelial Ovarian Carcinoma

  2002cites this paper
• Epidermal Growth Factor-Related Peptides in Endocrine Neoplasias

  2000cites this paper
• Soluble p185/her2 and S100 in yolk sac blood from human melanoma metastases xenotransplanted to chick embryo chorioallantoic membrane.

  2000cites this paper
• The growth factor receptors HER-2/neu and EGFR, their relationship, and their effects on the prognosis in early stage (FIGO I-II) epithelial ovarian carcinoma

  2000cites this paper
• Expression and Function of Egf-Related Peptides and Their Receptors in Gynecological Cancer - From Basic Science to Therapy?

  2000cites this paper
• Expression of c‐erbB receptors, heregulin and oestrogen receptor in human breast cell lines

  2000cites this paper